1. Home
  2. NVEC vs RIGL Comparison

NVEC vs RIGL Comparison

Compare NVEC & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVEC
  • RIGL
  • Stock Information
  • Founded
  • NVEC 1989
  • RIGL 1996
  • Country
  • NVEC United States
  • RIGL United States
  • Employees
  • NVEC N/A
  • RIGL N/A
  • Industry
  • NVEC Semiconductors
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVEC Technology
  • RIGL Health Care
  • Exchange
  • NVEC Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • NVEC 315.7M
  • RIGL 537.6M
  • IPO Year
  • NVEC 1996
  • RIGL 2000
  • Fundamental
  • Price
  • NVEC $72.37
  • RIGL $29.94
  • Analyst Decision
  • NVEC
  • RIGL Buy
  • Analyst Count
  • NVEC 0
  • RIGL 5
  • Target Price
  • NVEC N/A
  • RIGL $38.20
  • AVG Volume (30 Days)
  • NVEC 40.5K
  • RIGL 498.1K
  • Earning Date
  • NVEC 10-22-2025
  • RIGL 11-04-2025
  • Dividend Yield
  • NVEC 5.50%
  • RIGL N/A
  • EPS Growth
  • NVEC N/A
  • RIGL N/A
  • EPS
  • NVEC 2.85
  • RIGL 5.43
  • Revenue
  • NVEC $24,784,396.00
  • RIGL $267,921,000.00
  • Revenue This Year
  • NVEC N/A
  • RIGL $59.93
  • Revenue Next Year
  • NVEC N/A
  • RIGL N/A
  • P/E Ratio
  • NVEC $25.53
  • RIGL $5.51
  • Revenue Growth
  • NVEC N/A
  • RIGL 105.62
  • 52 Week Low
  • NVEC $51.50
  • RIGL $13.57
  • 52 Week High
  • NVEC $88.50
  • RIGL $43.72
  • Technical
  • Relative Strength Index (RSI)
  • NVEC 59.26
  • RIGL 49.33
  • Support Level
  • NVEC $70.01
  • RIGL $29.30
  • Resistance Level
  • NVEC $79.00
  • RIGL $31.92
  • Average True Range (ATR)
  • NVEC 2.96
  • RIGL 1.53
  • MACD
  • NVEC 0.13
  • RIGL 0.46
  • Stochastic Oscillator
  • NVEC 53.10
  • RIGL 65.52

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: